Posts  / HIMS  / #POST-238256
REDDIT

SqueezeFinder - March 9th 2026

S
Mar 9, 2026 Β· 12:08

https://preview.redd.it/10rh9sx0g0og1.png?width=2104&format=png&auto=webp&s=092f4e3e5364e7fd653414f6910ddae6ab47dda4

Good morning, SqueezeFinders!

The market is in another freefall overnight with the $QQQ tech index down \~2.3% with session lows of 583.77. After the close on Friday of 599.75 (-1.5%), the bears didn't wait a moment to slam us down after failing to close above 600. The main reason for the sell-off is the escalating U.S.-Iran military conflict (including U.S./Israel strikes on Iran, Iranian retaliation, and threats to close the Strait of Hormuz). This has driven a surge in oil prices (as detailed below), stoking inflation fears, higher borrowing costs, supply disruption risks, and broader geopolitical uncertainty. The bulls need to hold 580, or we risk seeing a collapse down towards 560 in the near-term. It's very likely (hopeful cope) we can see a full-day intraday reversal/bounce due to extreme oversold conditions. However, do not be cocky in this market, as it is high risk/high reward. If bulls can reclaim 600, and close above it, it could be time to think if sellers are finally exhausted. The main things to pay attention to today for directional sentiment determinants is ongoing headline developments regarding the ongoing Iran military escalation. Regardless of broader market conditions, you can always locate relative strength by tapping/clicking the column headers to sort the life watchlist in descending order of whichever data metric is important to you. Also remember to use our SqueezeRadar tool to locate tickers showing irregular movement in a given data metric. Stay tuned as we continue to see improvement in the consistency of SqueezeBot's win rate % (with real money).

πŸ₯‡ Gold: \~$5,100/oz (-1.3%)
πŸ₯ˆ Silver: \~$83/oz (-1.6%)
πŸͺ™ Bitcoin: \~$67.3k/coin (+0.3%)
πŸ›’οΈ Oil: \~$115.7/barrel (+27.3%)

Today's economic data releases are:

πŸ‡ΊπŸ‡Έ No scheduled economic data releases today.

πŸ“™Breakdown point: BELOW this price, the move will lose momentum significantly in the short-term, as shorts will gain confidence encouraging them to short more. Reducing probability of a squeeze without a catalyst.

πŸ“™Breakout point: ABOVE this price, the move will gain momentum significantly in the short-term, as shorts losses will increase pressuring them to cover. Increasing the probability of a squeeze occurring, especially if with a catalyst.

4. $HIMS
Squeezability Score: 44%
Juice Target: 73.1
Confidence: 🍊 🍊
Price: 15.74 (-0.88%) / Limit up 20% in overnight trading.
Breakdown point: \~16 (implies gap fill from overnight gap)
Breakout point: 19.6 (gap fill to \~21.1)
Mentions (30D): 0 πŸ†•
Event/Condition: Spike on Friday in AH on news they will be partnering with Novo Nordisk to sell obesity drugs + Potentially imminent gap fill from 19.6 towards 21.1 + Potentially imminent medium-term downtrend bullish reversal + Q4 revenue $617.8M up 28% YoY with full-year 2025 revenue $2.35B surging 59% and subscriber growth to over 2.5M driving strong profitability metrics + agreement to acquire Eucalyptus for international acceleration into new markets like Australia and Japan expanding the consumer health platform footprint + launch of multi-cancer early detection testing enhancing proactive care offerings alongside recent Novo Nordisk partnership for branded GLP-1 drugs resolving prior compounded uncertainties + Recent price target 🎯 of $25 from Barclays + Recent price target 🎯 of $21 from Morgan Stanley + Recent price target 🎯 of $24 from Evercore ISI.

5. $HNST
Squeezability Score: 43%
Juice Target: 5.8
Confidence: 🍊 🍊
Price: 2.93 (+0.34%)
Breakdown point: 2.7
Breakout point: 3.0
Mentions (30D): 3
Event/Condition: Potentially imminent medium-term downtrend bullish reversal + Elevated rel vol + Potentially imminent gap fill from \~3 to \~3.3 + Q4 revenue in line with expectations amid ongoing transformation and margin strengthening + $25M share repurchase program authorized to return capital and signal confidence in balance sheet + new Sensitive Rich Cream launch expanding skincare portfolio for sensitive skin across all ages + Recent price target 🎯 of $3.50 from B. Riley + Recent price target 🎯 of $3.50 from Alliance Global Partners + Recent price target 🎯 of $3.00 from Telsey Advisory Group.

Gain access to all our cutting-edge research tools, live watchlists, alerts, and more: [https://www.squeeze-finder.com/subscribe](https://www.squeeze-finder.com/subscribe)

HINT: Use code RDDT to get your first month for just $10!

NOT FINANCIAL ADVICE, THESE POSTS ARE FOR INFORMATIONAL PURPOSES ONLY